Betterment LLC’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$502K Buy
1,996
+196
+11% +$42.2K ﹤0.01% 480
2026
Q1
$391K Buy
1,800
+73
+4% +$16.2K ﹤0.01% 485
2025
Q4
$395K Buy
1,727
+290
+20% +$66.1K ﹤0.01% 450
2025
Q3
$333K Sell
1,437
-7
-0.5% -$1.43K ﹤0.01% 441
2025
Q2
$268K Sell
1,444
-35
-2% -$6.5K ﹤0.01% 450
2025
Q1
$310K Sell
1,479
-558
-27% -$108K ﹤0.01% 399
2024
Q4
$362K Buy
2,037
+12
+0.6% +$2.21K ﹤0.01% 359
2024
Q3
$400K Sell
2,025
-111
-5% -$20.7K ﹤0.01% 336
2024
Q2
$366K Buy
2,136
+246
+13% +$40.8K ﹤0.01% 321
2024
Q1
$344K Buy
+1,890
New +$326K ﹤0.01% 296

Other funds holding ABBV

Betterment LLC's ABBV Position: Q2 2026 in Review

Betterment LLC increased its AbbVie (ABBV) stake by 11% in Q2 2026, buying an estimated $42.2K and bringing the position to 1,996 shares worth $502K. The position accounts for ﹤0.01% of the portfolio, ranked #480.

Betterment LLC first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Betterment LLC held 1,996 shares of AbbVie worth $502K as of Q2 2026.
  • Betterment LLC bought 196 AbbVie shares in Q2 2026, an estimated $42.2K.
  • AbbVie made up ﹤0.01% of Betterment LLC's portfolio in Q2 2026, its #480 holding.
  • Betterment LLC first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Betterment LLC's 13F filing for Q2 2026, filed 14 Aug 2026.